rs367685759
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001365276.2(TNXB):c.9661G>C(p.Val3221Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,612,400 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V3221M) has been classified as Likely benign.
Frequency
Consequence
NM_001365276.2 missense
Scores
Clinical Significance
Conservation
Publications
- Ehlers-Danlos syndromeInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome due to tenascin-X deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
- familial vesicoureteral refluxInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- vesicoureteral reflux 8Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TNXB | NM_001365276.2 | c.9661G>C | p.Val3221Leu | missense_variant | Exon 28 of 44 | ENST00000644971.2 | NP_001352205.1 | |
| TNXB | NM_001428335.1 | c.10402G>C | p.Val3468Leu | missense_variant | Exon 29 of 45 | NP_001415264.1 | ||
| TNXB | NM_019105.8 | c.9655G>C | p.Val3219Leu | missense_variant | Exon 28 of 44 | NP_061978.6 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TNXB | ENST00000644971.2 | c.9661G>C | p.Val3221Leu | missense_variant | Exon 28 of 44 | NM_001365276.2 | ENSP00000496448.1 | |||
| TNXB | ENST00000647633.1 | c.10402G>C | p.Val3468Leu | missense_variant | Exon 29 of 45 | ENSP00000497649.1 | ||||
| TNXB | ENST00000375244.7 | c.9661G>C | p.Val3221Leu | missense_variant | Exon 28 of 44 | 5 | ENSP00000364393.3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152194Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000405 AC: 1AN: 247064 AF XY: 0.00000744 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460206Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726440 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152194Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74350 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Cardiovascular phenotype Uncertain:1
The p.V3219L variant (also known as c.9655G>C), located in coding exon 27 of the TNXB gene, results from a G to C substitution at nucleotide position 9655. The valine at codon 3219 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at